Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

Example Group: NCT03421379 Eligibility Criteria

version: 10; Last updated: 2025-12-11 20:35:21+0000; Language: en

Artifact Author: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter:

CiteAs:

NCT03421379 Eligibility Criteria [Database Entry: FHIR Group Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 267225. Revised 2025-12-11. Available at: https://fevir.net/resources/Group/267225. Computable resource at: https://fevir.net/resources/Group/267225#json.

url: https://fevir.net/resources/Group/267225

identifier: FEvIR Object Identifier/267225, FEvIR Linking Identifier/NCT03421379 Eligibility Criteria

name: NCT03421379_Eligibility_Criteria

title: NCT03421379 Eligibility Criteria

status: Active

publisher: Computable Publishing LLC

contact: support@computablepublishing.com

description:

Inclusion Criteria:

  • Participants with Type 1 diabetes (T1D) or Type 2 diabetes (T2D)
  • Body mass Index (BMI) of 18.5 to 30.0 kilograms per meter squared (kg/m2) for T1D, or 18.5 to 35.0 kg/m2 for T2D
  • Hemoglobin A1c (HbA1c) ≤10% Exclusion Criteria:
  • Have significant changes in insulin regimen and/ or unstable blood sugar control within the past 3 month
  • Have received a total daily dose of insulin >1.2 units per kilogram (U/kg)

copyright:

https://creativecommons.org/licenses/by-nc-sa/4.0/

membership: Conceptual

combinationMethod: All of

characteristic

code: Defined by CodeableConcept

value: Participants with Type 1 diabetes (T1D) or Type 2 diabetes (T2D)

exclude: false

characteristic

code: Defined by CodeableConcept

value: Body mass Index (BMI) of 18.5 to 30.0 kilograms per meter squared (kg/m2) for T1D, or 18.5 to 35.0 kg/m2 for T2D

exclude: false

characteristic

code: Defined by CodeableConcept

value: Hemoglobin A1c (HbA1c) ≤10%

exclude: false

characteristic

code: Defined by CodeableConcept

value: Have significant changes in insulin regimen and/ or unstable blood sugar control within the past 3 month

exclude: true

characteristic

code: Defined by CodeableConcept

value: Have received a total daily dose of insulin \>1.2 units per kilogram (U/kg)

exclude: true